The American Academy of Audiology (AAA) has published an article on its website discussing the potential ototoxicity of quinine derivatives that may be utilized for COVID-19.
The article states: “The hearing loss, tinnitus (perception of ringing, buzzing, humming without an external source), and balance effects of hydroxychloroquine/chloroquine are often only temporary in nature. The drug can create a transient change in the function of the inner ear. This change usually reverses once the treatment is discontinued.”
AAA recommends that patients treated with these drugs limit their exposure to loud noise and/or use hearing protection to guard against further hearing damage.
To read the article in its entirety, please click here.